玖玖资源网站,爆乳久久久,日韩精品乱码久久久蜜桃,精品呦国产一区二区三区,国产伦高清一区二区三区,sese一区二区,午夜精品福利一区二区三区,三级黄色网站久久免费

產(chǎn)品中心

Product center

OSU-T315 99%

OSU-T315

源葉(MedMol)
S82868
1333146-24-9
C30H30F3N5O
533.5873
品牌 貨號 產(chǎn)品規(guī)格 價格(RMB) 庫存(上海) 北京 武漢 南京 購買數(shù)量
源葉(MedMol) S82868-1mg 99% ¥400.00元 10 - - -
源葉(MedMol) S82868-2mg 99% ¥650.00元 10 - - -
源葉(MedMol) S82868-5mg 99% ¥1000.00元 >10 - - -
源葉(MedMol) S82868-10mg 99% ¥1300.00元 >10 - - -
產(chǎn)品介紹 參考文獻 質檢證書(COA) 摩爾濃度計算器 相關產(chǎn)品

產(chǎn)品介紹

OSU-T315 is a novel potent, orally active ILK (integrin-linked kinase) inhibitor with IC50 of 0.6 μM.
產(chǎn)品描述: OSU-T315 is a novel potent, orally active ILK (integrin-linked kinase) inhibitor with IC50 of 0.6 μM.
靶點: Integrin
體外研究:
OSU-T315 exhibited high in vitro potency against a panel of prostate and breast cancer cell lines (IC(50), 1-2.5 μM), while normal epithelial cells were unaffected. OSU-T315 facilitated the dephosphorylation of Akt at Ser-473 and other ILK targets, including glycogen synthase kinase-3β and myosin light chain. Moreover, OSU-T315 suppressed the expression of the transcription/translation factor YB-1 and its targets HER2 and EGFR in PC-3 cells, which could be rescued by the stable expression of constitutively active ILK. The cytotoxicity of OSU-T315 in normal B or T cells was significantly lower (LC50 > 10 μM). OSU-T315 had the effect of dose-dependent cytotoxicity toward 2 CLL-derived cell lines, Mec-1 and OSU-CLL (LC50 of 2-3 μM in both) after 24-hour treatment
體內研究:
Athymic nude mice bearing established subcutaneous PC-3 tumors were treated with oral OSU-T315 once daily at 25 and 50 mg/kg or vehicle control. The daily administration of OSU-T315 at both doses was well tolerated. Treatment with oral OSU-T315 in either dose resulted in significant suppression of tumor growth relative to the vehicle control after 35 days of treatment (48% and 62% suppression for 25 and 50 mg/kg, respectively)
參考文獻:
1. Liu TM, et al. OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells. Blood. 2015 Jan 8;125(2):284-95. 2. Lee SL, et al. Identification and characterization of a novel integrin-linked kinase inhibitor. J Med Chem. 2011 Sep 22;54(18):6364-74.
溶解性: Soluble  in  DMSO
保存條件: -20℃
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 1.874 ml 9.371 ml 18.741 ml
5 mM 0.375 ml 1.874 ml 3.748 ml
10 mM 0.187 ml 0.937 ml 1.874 ml
50 mM 0.037 ml 0.187 ml 0.375 ml
注意: 部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。

參考文獻

質檢證書(COA)

如何獲取質檢證書(COA)?
請輸入貨號和一個與之匹配的批號。
例如:
批號:C10000001 貨號:A800001-25g
在貨品標簽上如何找到貨號和批號?

摩爾濃度計算器

質量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×

相關產(chǎn)品

主站蜘蛛池模板: 信丰县| 和硕县| 乐山市| 铜梁县| 巴南区| 磴口县| 九龙县| 麦盖提县| 黔江区| 弥勒县| 五家渠市| 平山县| 鄂温| 绥滨县| 桐庐县| 新竹县| 西峡县| 韩城市| 北京市| 林口县| 临江市| 奇台县| 永仁县| 静宁县| 贺州市| 平武县| 黎川县| 邢台县| 双柏县| 文成县| 仁怀市| 萝北县| 醴陵市| 江都市| 清水河县| 阿拉善左旗| 东光县| 苏州市| 玛曲县| 南木林县| 图木舒克市|